The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.
The global angioplasty balloons market reached a value of US$ 2.4 Billion in 2020. Looking forward, IMARC Group expects the market to grow at a CAGR of 3.21% during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
Angioplasty balloons refer to the medical devices that are used for unblocking and widening clogged blood vessels during surgical procedures. Some of the common types of angioplasty balloons include drug-eluting, normal, scoring and cutting balloons. They are usually manufactured using nylon, polyurethane and silicone urethane polymers and consist of nitinol constraining structures that create grooves and pillows on the surface of the balloon to offer predictable, uniform and atraumatic dilation. During the surgery, the balloon is inflated to flatten the plaque against the wall of the blood vessels, thereby opening them and restoring the normal blood flow.
The increasing prevalence of coronary and periphery artery diseases across the globe is one of the key factors driving the growth of the market. In line with this, the rising geriatric population and individuals suffering from obesity and high levels of cholesterol are also providing a boost to the market growth. Furthermore, there is an increasing preference for drug-coated angioplasty balloons that offer superior safety, effectiveness and improved blood flow throughout the body. This has also reduced the utilization of vessel implants, such as stents, which may cause vessel fracture. Additionally, various technological advancements, such as the development of imaging technologies, and the advent of innovative variants that can be implanted without administering general anesthesia, are also acting as major growth-inducing factors. Increasing health consciousness among consumers, improving healthcare infrastructure and extensive research and development (R&D) activities in the field of medical sciences are some of the other factors that are projected to drive the market further.
IMARC Group provides an analysis of the key trends in each sub-segment of the global angioplasty balloons market, along with forecasts at the global, regional and country level from 2021-2026. Our report has categorized the market based on product type, application, material and end-user.
Breakup by Product Type:
Breakup by Application:
Breakup by Material:
Breakup by End-User:
Breakup by Region:
The report has also analysed the competitive landscape of the market with some of the key players being Abbott Laboratories, B. Braun Melsungen AG, BD (Becton, Dickinson, and Company), Biotronik SE & Co. KG, Boston Scientific Corporation, Cardinal Health Inc., Cook Medical LLC, Endocor GmbH & Co. KG, Johnson & Johnson, Medtronic Inc., Terumo Corporation, etc.
|Base Year of the Analysis||2020|
|Segment Coverage||Product Type, Application, Material, End-User, Region|
|Region Covered||Asia Pacific, Europe, North America, Latin America, Middle East and Africa|
|Countries Covered||United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico|
|Companies Covered||Abbott Laboratories, B. Braun Melsungen AG, BD (Becton, Dickinson, and Company), Biotronik SE & Co. KG, Boston Scientific Corporation, Cardinal Health Inc., Cook Medical LLC, Endocor GmbH & Co. KG, Johnson & Johnson, Medtronic Inc. and Terumo Corporation|
|Customization Scope||10% Free Customization|
|Report Price and Purchase Option||Single User License: US$ 2299
Five User License: US$ 3399
Corporate License: US$ 4499
|Post-Sale Analyst Support||10-12 Weeks|
|Delivery Format||PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)|
Key Questions Answered in This Report:
REACH OUT TO US
Call us on
( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )
Drop us an email at